Ovid Therapeutics

(NASDAQ) OVID

Current Price$2.63

Market Cap$490.86M

Since IPO (2017)-79%

5 Year-27%

1 Year+761%

1 Month-5%

Ovid Therapeutics Financials at a Glance

Market Cap

$490.86M

Revenue (TTM)

$7.12M

Net Income (TTM)

$24.17M

EPS (TTM)

$-0.24

P/E Ratio

-10.81

Dividend

$0.00

Beta (Volatility)

0.87 (Low)

Dividend

$0.00

Beta (Volatility)

0.87 (Low)

Price

$2.63

Volume

32,648

Open

$2.77

Price

$2.63

Volume

32,648

Open

$2.77

Previous Close

$2.63

Daily Range

$2.61 - $2.77

52-Week Range

$0.27 - $3.10

Dividend

$0.00

Beta (Volatility)

0.87 (Low)

Price

$2.63

Volume

32,648

Open

$2.77

Previous Close

$2.63

Daily Range

$2.61 - $2.77

52-Week Range

$0.27 - $3.10

OVID News

Here's Why Ovid Therapeutics Stock Popped Higher Today

Lee SamahaMar 18, 2026

Why Ovid Therapeutics Stock Is Imploding Today

Prosper Junior BakinyDec 2, 2020

3 Top Biotech Stocks to Buy Now

Zhiyuan SunJul 25, 2020

Is Ovid Therapeutics Stock a Buy?

Prosper Junior BakinyJul 14, 2020

Why Ovid Therapeutics Stock Is Soaring Today

Prosper Junior BakinyJun 18, 2020

OVID: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ovid Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Margaret Alexander

Website

www.ovidrx.com

Headquarters

New York City, NY 10036, US

OVID Financials

Key Financial Metrics (TTM)

Gross Margin

100%

Operating Margin

-7%

Net Income Margin

-3%

Return on Equity

-19%

Return on Capital

-23%

Return on Assets

-11%

Earnings Yield

-9.25%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$490.86M

Shares Outstanding

186.64M

Volume

32.65K

Avg. Volume

3.13M

Financials (TTM)

Gross Profit

$6.95M

Operating Income

$42.44M

EBITDA

$42.14M

Operating Cash Flow

$38.33M

Capital Expenditure

$0.00

Free Cash Flow

$38.33M

Cash & ST Invst.

$69.64M

Total Debt

$13.42M

Ovid Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$35.00K

-126.9%

Gross Margin

0.00%

N/A

Market Cap

$490.86M

N/A

Market Cap/Employee

$21.34M

N/A

Employees

N/A

Net Income

$16.99M

-66.0%

EBITDA

$17.81M

-43.5%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$154.06M

+439.3%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

-100.0%

Short Term Debt

$1.46M

+7.3%

Return on Assets

-10.71%

N/A

Return on Invested Capital

-22.74%

N/A

Free Cash Flow

$13.90M

-35.2%

Operating Cash Flow

$13.90M

-35.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

STTKShattuck Labs, Inc.

STTKShattuck Labs, Inc.$6.26-6.15%

MGNXMacroGenics, Inc.

MGNXMacroGenics, Inc.$4.25+2.16%

WHWKWhitehawk Therapeutics Inc

WHWKWhitehawk Therapeutics Inc$4.70-7.84%

CNTXContext Therapeutics Inc.

CNTXContext Therapeutics Inc.$2.16-7.30%

ORMPOramed Pharmaceuticals Inc.

ORMPOramed Pharmaceuticals Inc.$4.64-1.90%

IFRXInflaRx N.V.

IFRXInflaRx N.V.$2.47+3.78%

CNTBConnect Biopharma Holdings Limited

CNTBConnect Biopharma Holdings Limited$2.38-4.03%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$108.77-0.06%

NOKNokia

NOKNokia$13.95-0.04%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.06-0.10%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$75.34-0.05%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.98+0.05%

PIIIP3 Health Partners

PIIIP3 Health Partners$11.29+1.80%

AAPLApple

AAPLApple$300.23+0.01%

Questions About OVID

What is the current price of Ovid Therapeutics?

Ovid Therapeutics is trading at $2.63 per share.

What is the 52-week range for Ovid Therapeutics?

Over the past 52 weeks, Ovid Therapeutics has traded between $0.27 and $3.11.

How much debt does Ovid Therapeutics have?

As of the most recent reporting period, Ovid Therapeutics reported total debt of $13.07M.

How much cash does Ovid Therapeutics have on hand?

Ovid Therapeutics reported $94.06M in cash and cash equivalents in its most recent financial results.

What is Ovid Therapeutics’s dividend yield?

Ovid Therapeutics does not currently have a dividend yield.

Ovid Therapeutics

Ovid Therapeutics Financials at a Glance

OVID News

Here's Why Ovid Therapeutics Stock Popped Higher Today

Why Ovid Therapeutics Stock Is Imploding Today

3 Top Biotech Stocks to Buy Now

Is Ovid Therapeutics Stock a Buy?

Why Ovid Therapeutics Stock Is Soaring Today

OVID: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Ovid Therapeutics

OVID Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Ovid Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About OVID

What is the current price of Ovid Therapeutics?

What is the 52-week range for Ovid Therapeutics?

How much debt does Ovid Therapeutics have?

How much cash does Ovid Therapeutics have on hand?

What is Ovid Therapeutics’s dividend yield?

Premium Investing Services